Skip to main content
Clinical Trials/ISRCTN12928573
ISRCTN12928573
Active, not recruiting
未知

Effect of a multi-ingredient based food supplement on sexual function in women with low sexual desire. Pilot study.

Instituto Palacios de Salud y Medicina de la Mujer0 sites29 target enrollmentMarch 28, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Instituto Palacios de Salud y Medicina de la Mujer
Enrollment
29
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31039769 (added 02/05/2019)

Registry
who.int
Start Date
March 28, 2019
End Date
August 31, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Instituto Palacios de Salud y Medicina de la Mujer

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy, postmenopausal women (no natural menses for at least 1 year) aged \= 45 and \= 65\. Hysterectomized patients should have an FSH level above 40 IU.
  • 2\. Stable partner, living together for at least 15 days a month and being sexually available.
  • 3\. Risk of sexual dysfunction established at FSFI score\< 25\.83\.
  • 4\. Integrity of the vaginal mucosa (without lesions or bleeding).
  • 5\. Women willing to and capable of understanding and signing an informed consent after receiving an explanation on the nature of the whole study.
  • 6\. Consenting to participate in the study and signing the Informed Consent form.
  • 7\. No desire for pregnancy in the next 3 months.

Exclusion Criteria

  • 1\. Pregnant women or with suspected pregnancy.
  • 2\. Within 3 months following delivery or abortion.
  • 3\. Breastfeeding women.
  • 4\. Women with severe pain in sexual relationships (DMS\-V).
  • 5\. Non\-diagnosed abnormal genital bleeding or presence of vaginal lesions.
  • 6\. Women with symptoms of vaginal infection or signs of any other genital infection.
  • 7\. Women allergic or hypersensitive to the components of the study treatment.
  • 8\. Severe psychiatric disorder.
  • 9\. Use of any hormonal treatment with estrogens, progestogens, or estrogens and progestogens within 3 previous months prior to selection.
  • 10\. Use of any other drug or experimental device within 30 days prior to selection.

Outcomes

Primary Outcomes

Not specified

Similar Trials